ArticleFrontiers in bioengineering and biotechnology2026
A biohybrid nanovesicle hijacks inflammatory chemotaxis to deliver colchicine for myocardial infarction therapy.
Xiangyong Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.